Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Adalimumab
Humira
Not routinely available
SMC (1208/16)
07/11/2016
Indication
Treatment of moderately active Crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and a corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such ther...
Therapeutic Area
Gastro-intestinal system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
40mg/0.4ml and 40mg/0.8ml Pre-filled Syringe and Pre-filled Pen, 40mg/0.8ml vial for paediatric use
Comments
None
Link to Advice
Advice Published
07/11/2016
SMC Submission Type
Non submission
SMC Status
Not recommended